Duration of HIV-1 viral suppression on cessation of antiretroviral therapy in primary infection correlates with time on therapy.
about
Enhancing Human Immunodeficiency Virus-Specific CD8(+) T Cell Responses with Heteroclitic PeptidesTranscriptional control of HIV latency: cellular signaling pathways, epigenetics, happenstance and the hope for a cureMulti-dose Romidepsin Reactivates Replication Competent SIV in Post-antiretroviral Rhesus Macaque ControllersDNA/MVA Vaccination of HIV-1 Infected Participants with Viral Suppression on Antiretroviral Therapy, followed by Treatment Interruption: Elicitation of Immune Responses without Control of Re-Emergent VirusPredicting the outcomes of treatment to eradicate the latent reservoir for HIV-1Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys.HIV-1 DNA predicts disease progression and post-treatment virological control.Post-treatment control of HIV infection.Immunological biomarkers predict HIV-1 viral rebound after treatment interruptionThe impact of transient combination antiretroviral treatment in early HIV infection on viral suppression and immunologic response in later treatment.Dysfunctional phenotypes of CD4+ and CD8+ T cells are comparable in patients initiating ART during early or chronic HIV-1 infectionVirological Blips and Predictors of Post Treatment Viral Control After Stopping ART Started in Primary HIV Infection.Post-treatment control or treated controllers? Viral remission in treated and untreated primary HIV infection.A cure for HIV: is it in sight?Preserving HIV-specific T cell responses: does timing of antiretroviral therapy help?Clinical and public health implications of acute and early HIV detection and treatment: a scoping review.Post-Treatment Controllers: Role in HIV "Cure" Research.Kill: boosting HIV-specific immune responses.Optimal control therapy and vaccination for special HIV-1 model with delay.The impact of immunoglobulin in acute HIV infection on the HIV reservoir: a randomized controlled trial.Brief Report: Prevalence of Posttreatment Controller Phenotype Is Rare in HIV-Infected Persons After Stopping Antiretroviral Therapy.A pilot evaluation of whole blood finger-prick sampling for point-of-care HIV viral load measurement: the UNICORN study.The pharmacological treatment of acute HIV infections in neonates.HIV replication and latency in a humanized NSG mouse model during suppressive oral combinational ART.Age at antiretroviral therapy initiation and cell-associated HIV-1 DNA levels in HIV-1-infected children.HIV control: Is getting there the same as staying there?
P2860
Q26800123-E0CE4BA2-0B4F-4F05-982D-9DD87D37666BQ26999858-9DCAD830-4253-49B8-ABBD-4DD755EE2FD3Q27312050-920CAC0B-BCEA-4A0E-924F-AF7AB86CEF2DQ28554534-57ED1910-64AB-4ECB-AEC9-C5791E89454CQ28655602-1E0B92C4-D6B7-40DC-B89C-F72EE2311821Q34020988-A7E1F327-80D2-4AE7-ADEA-489FD9F60B15Q34350410-60593E7A-11A8-4E85-A5C3-ABF3E6BC84D2Q35567047-176EACDC-41A6-4359-BB26-BD85A235969AQ36250043-0492C677-67C7-4F3C-B062-10B92BD11C07Q36692642-DC93ECC1-8F5A-45F2-9FD1-20F73AEC3B50Q37003624-3FD921AA-1E1E-4F10-9083-C3ABEB775D4BQ37582477-3023FEBF-54E4-490E-B951-0A2360DAC082Q37613230-4869D252-E5BB-4800-B1F0-EAD0845C95BEQ38205472-ABE404AF-4DEB-472F-B241-CD021B37CD16Q38267445-77D11831-98C4-4995-9621-0E9B448B1DDBQ38686953-CB9F3CA0-E693-4BAE-9697-2C7B18963BE9Q38701493-D57916FF-125F-477B-88AF-7F13741C673DQ38800533-0B724655-16F4-4ED7-B626-8E1BC3031D92Q39527190-41A269EA-87E9-4B81-9749-EE942895ABC0Q40118673-426054AE-48CD-4640-8CA7-78706665414AQ40250340-1E3FCA9C-4DC1-425D-B2A6-103D81908819Q42653332-A700A051-7BDD-4593-8431-6651AED787FEQ47591909-3AB5191F-63D1-4503-9F90-B531238A9D69Q49990061-A0C062C7-43AE-4714-93D3-8A5D05BD4ECDQ52591828-7F76E582-51A0-4929-8DDF-84D6EB8DB2E2Q58085173-5594F21F-206E-45A9-ACF3-B94D25EA9D56
P2860
Duration of HIV-1 viral suppression on cessation of antiretroviral therapy in primary infection correlates with time on therapy.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Duration of HIV-1 viral suppre ...... rrelates with time on therapy.
@ast
Duration of HIV-1 viral suppre ...... rrelates with time on therapy.
@en
type
label
Duration of HIV-1 viral suppre ...... rrelates with time on therapy.
@ast
Duration of HIV-1 viral suppre ...... rrelates with time on therapy.
@en
prefLabel
Duration of HIV-1 viral suppre ...... rrelates with time on therapy.
@ast
Duration of HIV-1 viral suppre ...... rrelates with time on therapy.
@en
P2093
P2860
P50
P1433
P1476
Duration of HIV-1 viral suppre ...... rrelates with time on therapy.
@en
P2093
Abdel Babiker
David Cooper
Jonathan Weber
Mauro Schechter
Rodney E Phillips
Sarah Fidler
P2860
P304
P356
10.1371/JOURNAL.PONE.0078287
P407
P577
2013-10-25T00:00:00Z